ArticleMetabolites2023

Metabolomics Analysis Reveals Altered Metabolic Pathways and Response to Doxorubicin in Drug-Resistant Triple-Negative Breast Cancer Cells.

Blake R Rushing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.